• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六氢吡咯并[2,3-]吲哚类化合物作为治疗阿尔茨海默病的潜在药物。

Hexahydropyrrolo[2,3-]indole Compounds as Potential Therapeutics for Alzheimer's Disease.

机构信息

Centro de Biología Celular y Molecular de Enfermedades , Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP) , City of Knowledge Edif #208 , Panama 0843-01103 , Panama.

Department of Biotechnology , Acharya Nagarjuna University , Nagarjuna Nagar , Guntur , Andhra Pradesh 522510 , India.

出版信息

ACS Chem Neurosci. 2019 Oct 16;10(10):4250-4263. doi: 10.1021/acschemneuro.9b00297. Epub 2019 Oct 7.

DOI:10.1021/acschemneuro.9b00297
PMID:31545596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8130500/
Abstract

Alzheimer's disease (AD) is the most common form of dementia among the elderly and has become a leading public health concern worldwide. It represents a huge economic and psychological burden to caregivers and families. The presence of extracellular amyloid beta (Aβ) plaques is one of the hallmarks of this neurodegenerative disorder. Amyloid plaques are comprised of aggregates of Aβ peptides, mainly Aβ, originated by the cleavage of the amyloid precursor protein (APP). Aβ is a crucial target for the treatment of AD, but to date, no effective treatment for the clearance of Aβ has been found. We have identified four new hexahydropyrroloindoles (HPI) synthetic compounds that are able to inhibit the aggregation of Aβ and/or disaggregate the fibril. Docking experiments suggest that the nonpolar component of the interaction of compounds with Aβ contributes favorably to the binding free energy of each complex. Molecular dynamics simulations suggested fibril disaggregating activity of compounds via interaction with hydrophobic moieties of the fibril. Consistently, compounds and were able to mitigate Aβ fibrils induced death in rat pheochromocytoma cells (PC 12). One of the compounds reduces the formation of Aβ aggregates and the paralysis associated with Aβ toxicity in . Our study thus augments efforts for the identification and characterization of new agents that may help stop or delay the progression of AD.

摘要

阿尔茨海默病(AD)是老年人中最常见的痴呆症形式,已成为全球主要的公共卫生关注问题。它给护理人员和家庭带来了巨大的经济和心理负担。细胞外淀粉样蛋白β(Aβ)斑块的存在是这种神经退行性疾病的标志之一。淀粉样斑块由 Aβ肽的聚集物组成,主要是由淀粉样前体蛋白(APP)切割产生的 Aβ。Aβ是治疗 AD 的重要靶点,但迄今为止,尚未发现有效的 Aβ清除治疗方法。我们已经确定了四种新的六氢吡咯并吲哚(HPI)合成化合物,它们能够抑制 Aβ的聚集和/或解聚纤维。对接实验表明,化合物与 Aβ相互作用的非极性部分有利于每个复合物的结合自由能。分子动力学模拟表明,化合物通过与纤维的疏水性部分相互作用具有纤维解聚活性。一致地,化合物 和 能够减轻 Aβ纤维诱导的大鼠嗜铬细胞瘤细胞(PC12)死亡。其中一种化合物减少了 Aβ聚集的形成 以及 Aβ毒性相关的麻痹 。因此,我们的研究增强了识别和表征可能有助于阻止或延缓 AD 进展的新药物的努力。

相似文献

1
Hexahydropyrrolo[2,3-]indole Compounds as Potential Therapeutics for Alzheimer's Disease.六氢吡咯并[2,3-]吲哚类化合物作为治疗阿尔茨海默病的潜在药物。
ACS Chem Neurosci. 2019 Oct 16;10(10):4250-4263. doi: 10.1021/acschemneuro.9b00297. Epub 2019 Oct 7.
2
N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.丹参酮或其类似物在抑制淀粉样蛋白聚集和已形成淀粉样纤维解聚方面的N端结合偏好——迈向引入一种新型抗阿尔茨海默病化合物
ACS Chem Neurosci. 2017 Jul 19;8(7):1577-1588. doi: 10.1021/acschemneuro.7b00080. Epub 2017 Apr 28.
3
Insulin Inhibits Aβ42 Aggregation and Prevents Aβ42-Induced Membrane Disruption.胰岛素抑制 Aβ42 聚集并防止 Aβ42 诱导的膜破坏。
Biochemistry. 2019 Nov 12;58(45):4519-4529. doi: 10.1021/acs.biochem.9b00696. Epub 2019 Nov 4.
4
Peptide-Based Strategies: Combating Alzheimer's Amyloid β Aggregation through Ergonomic Design and Fibril Disruption.基于肽的策略:通过人体工程学设计和纤维破坏来对抗阿尔茨海默病淀粉样 β 聚集。
Biochemistry. 2024 Oct 1;63(19):2397-2413. doi: 10.1021/acs.biochem.4c00371. Epub 2024 Sep 10.
5
Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.黄烷酮糖苷抑制β-淀粉样前体蛋白裂解酶 1 和乙酰胆碱酯酶,并减少淀粉样蛋白生成途径中 Aβ 的聚集。
Chem Biol Interact. 2019 Aug 25;309:108707. doi: 10.1016/j.cbi.2019.06.020. Epub 2019 Jun 11.
6
Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.静息态小胶质细胞对Aβ42纤维有反应,但无法检测到寡聚体或寡聚体诱导的神经元损伤。
Neurobiol Aging. 2014 Nov;35(11):2444-2457. doi: 10.1016/j.neurobiolaging.2014.05.023. Epub 2014 May 29.
7
Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea.绿茶中的表没食子儿茶素和表儿茶素-3-没食子酸酯抑制阿尔茨海默病中的 Aβ 聚集物。
Bioorg Chem. 2020 Dec;105:104382. doi: 10.1016/j.bioorg.2020.104382. Epub 2020 Oct 15.
8
Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.阿尔茨海默病治疗药物研发的最新进展——特别是对淀粉样肽聚集的抑制作用。
Mini Rev Med Chem. 2021;21(8):969-990. doi: 10.2174/1389557520666201127104539.
9
Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.羧苄青霉素对阿尔茨海默病β淀粉样蛋白体外聚集的抑制作用:作用机制探究
Neurochem Int. 2017 Sep;108:481-493. doi: 10.1016/j.neuint.2017.06.011. Epub 2017 Jun 24.
10
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.非典型可溶性淀粉样β聚集体与斑块缓冲:阿尔茨海默病靶点发现的争议与未来方向
Alzheimers Res Ther. 2017 Aug 17;9(1):62. doi: 10.1186/s13195-017-0293-3.

引用本文的文献

1
Neuroprotective Potential of Indole-Based Compounds: A Biochemical Study on Antioxidant Properties and Amyloid Disaggregation in Neuroblastoma Cells.基于吲哚的化合物的神经保护潜力:对神经母细胞瘤细胞抗氧化特性和淀粉样蛋白解聚的生化研究
Antioxidants (Basel). 2024 Dec 23;13(12):1585. doi: 10.3390/antiox13121585.
2
Destabilization of the Alzheimer's amyloid-β peptide by a proline-rich β-sheet breaker peptide: a molecular dynamics simulation study.富含脯氨酸的β-折叠破坏肽使阿尔茨海默病淀粉样-β肽失稳的分子动力学模拟研究。
J Mol Model. 2021 Nov 18;27(12):356. doi: 10.1007/s00894-021-04968-x.
3
A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease.

本文引用的文献

1
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms.不同可溶性 Aβ42 聚集体通过不同的机制引发细胞毒性。
Nat Commun. 2019 Apr 4;10(1):1541. doi: 10.1038/s41467-019-09477-3.
2
Trodusquemine enhances Aβ aggregation but suppresses its toxicity by displacing oligomers from cell membranes.曲多沙明通过从细胞膜上置换低聚物来增强 Aβ 聚集但抑制其毒性。
Nat Commun. 2019 Jan 15;10(1):225. doi: 10.1038/s41467-018-07699-5.
3
Developing a molecular dynamics force field for both folded and disordered protein states.
一种计算方法探索半合成含氮杂环化合物与 SARS-CoV-2 主蛋白酶的相互作用。
Biomolecules. 2020 Dec 27;11(1):18. doi: 10.3390/biom11010018.
为折叠和无序的蛋白质状态开发分子动力学力场。
Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4758-E4766. doi: 10.1073/pnas.1800690115. Epub 2018 May 7.
4
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?为何针对β淀粉样蛋白的研究未能为阿尔茨海默病带来新药?
ACS Chem Neurosci. 2017 Jul 19;8(7):1435-1437. doi: 10.1021/acschemneuro.7b00188. Epub 2017 Jun 6.
5
High-Resolution Structures of the Amyloid-β 1-42 Dimers from the Comparison of Four Atomistic Force Fields.四种原子力场对比分析得到的淀粉样β 1-42 二聚体的高分辨率结构
J Phys Chem B. 2017 Jun 22;121(24):5977-5987. doi: 10.1021/acs.jpcb.7b04689. Epub 2017 Jun 7.
6
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.鉴定CD36与β淀粉样蛋白结合的抑制剂作为阿尔茨海默病的潜在药物
ACS Chem Neurosci. 2017 Jun 21;8(6):1232-1241. doi: 10.1021/acschemneuro.6b00386. Epub 2017 Feb 15.
7
Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease.3-亚氨基-1,2,4-噻二嗪烷-1,1-二氧化物衍生物维鲁贝西他(MK-8931)的发现——一种用于治疗阿尔茨海默病的β-淀粉样前体蛋白裂解酶1抑制剂
J Med Chem. 2016 Dec 8;59(23):10435-10450. doi: 10.1021/acs.jmedchem.6b00307. Epub 2016 Nov 18.
8
Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases.淀粉样寡聚体与细胞膜的结合亲和力是蛋白质错误折叠疾病中细胞功能障碍的通用指标。
Sci Rep. 2016 Sep 13;6:32721. doi: 10.1038/srep32721.
9
Atomic-resolution structure of a disease-relevant Aβ(1-42) amyloid fibril.与疾病相关的Aβ(1-42)淀粉样纤维的原子分辨率结构。
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E4976-84. doi: 10.1073/pnas.1600749113. Epub 2016 Jul 28.
10
Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils.均相 Aβ42 淀粉样纤维的原子分辨率结构
J Am Chem Soc. 2016 Aug 3;138(30):9663-74. doi: 10.1021/jacs.6b05129. Epub 2016 Jul 14.